tradingkey.logo

AxoGen Inc

AXGN
View Detailed Chart

12.670USD

-0.420-3.21%
Close 08/01, 16:00ETQuotes delayed by 15 min
576.64MMarket Cap
LossP/E TTM

AxoGen Inc

12.670

-0.420-3.21%
Intraday
1m
30m
1h
D
W
M
D

Today

-3.21%

5 Days

-5.24%

1 Month

+15.92%

6 Months

-29.30%

Year to Date

-23.12%

1 Year

+56.42%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts
BUY
Current Rating
24.250
Target Price
91.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

95
Total
4
Median
7
Average
Company name
Ratings
Analysts
AxoGen Inc
AXGN
8
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(3)
Buy(3)
Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.115
Buy
RSI(14)
55.835
Neutral
STOCH(KDJ)(9,3,3)
50.451
Sell
ATR(14)
0.798
Low Volatility
CCI(14)
21.117
Neutral
Williams %R
54.777
Neutral
TRIX(12,20)
0.855
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
13.076
Sell
MA10
12.957
Sell
MA20
12.326
Buy
MA50
11.265
Buy
MA100
13.624
Sell
MA200
14.779
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Ticker SymbolAXGN
CompanyAxoGen Inc
CEOMr. Michael Donald (Mike) Dale
Websitehttps://www.axogeninc.com/
KeyAI